市場調査レポート

商品コード

1342081

創薬向けAIの世界市場の予測（～2030年）

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

出版日: 2023年09月01日 | 発行: Market Research Future

| ページ情報: 英文 132 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,950 775,665円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Multi User License)

USD 5,950 932,365円

レポートPDFを同一企業内の最大10名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Enterprise License)

USD 7,250 1,136,075円

レポートPDFを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の創薬向けAIの市場規模は、予測期間中にCAGRで29.83%の大幅な成長が予測されています。創薬向けAIの受け入れの増加や、創薬向けAIに対する主な取り組みの高まり、AIを活用する新しい創薬企業の増加が、事業部門の発展を促進しています。

地域の考察

北米市場が2022年にもっとも大きなシェアを占めました。

欧州市場が2番目に大きなシェアを占めています。

アジア太平洋市場が2023年～2030年に大きな伸びを示す見込みです。

中東・アフリカ・ラテンアメリカ市場は、慢性疾患や感染性疾患の流行による医薬品需要の増加により、発展する可能性が高いです。

当レポートでは、世界の創薬向けAI市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

バリューチェーン分析
- 研究開発
- 製造
- 流通、販売
- 販売後モニタリング
ポーターのファイブフォース分析モデル
世界の創薬向けAIに対するCOVID-19の影響
- サプライチェーンに対する影響
- サービス需要に対する影響
- 市場参入企業に対する影響

第6章世界の創薬向けAI市場：製品・サービス別

概要
ソフトウェア
サービス

第7章世界の創薬向けAI市場：分子タイプ別

概要
高分子
低分子

第8章世界の創薬向けAI市場：技術別

概要
機械学習
深層学習
その他

第9章世界の創薬向けAI市場：適応症別

概要
がん免疫
神経変性疾患
心血管疾患
代謝性疾患
その他

第10章世界の創薬向けAI市場：用途別

概要
標的の特定
候補のスクリーニング
de novo医薬品設計
医薬品の最適化と転用
前臨床試験

第11章世界の創薬向けAI市場：地域別

概要
北米
- 米国
- カナダ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他の欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋
その他の地域
- 中東
- アフリカ
- ラテンアメリカ

第12章競合情勢

概要
競合ベンチマーキング
世界の創薬向けAI市場の主な成長戦略
世界の創薬向けAI市場の開発数のリーダー
主な開発の分析
主な発展と成長戦略
- サービス/企業の立ち上げ
- 合併/買収
- パートナーシップ/提携/契約

第13章企業プロファイル

IBM
ALPHABET INC.
ATOMWISE INC.
DEEP GENOMICS
CLOUD PHARMACEUTICALS, INC.
MICROSOFT CORPORATION
INSILICO MEDICINE
CYCLICA
BENEVOLENTAI
EXSCIENTIA

第14章付録

図表

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 3 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRODUCT, BY REGION, 2019-2030 (USD BILLION)
TABLE 4 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SERVICES, BY REGION, 2019-2030 (USD BILLION)
TABLE 5 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 6 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR LARGE MOLECULE, BY REGION, 2019-2030 (USD BILLION)
TABLE 7 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SMALL MOLECULE, BY REGION, 2019-2030 (USD BILLION)
TABLE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR MACHINE LEARNING, BY REGION, 2019-2030 (USD BILLION)
TABLE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DEEP LEARNING, BY REGION, 2019-2030 (USD BILLION)
TABLE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 13 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR IMMUNO-ONCOLOGY, BY REGION, 2019-2030 (USD BILLION)
TABLE 14 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019-2030 (USD BILLION)
TABLE 15 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019-2030 (USD BILLION)
TABLE 16 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR METABOLIC DISEASES, BY REGION, 2019-2030 (USD BILLION)
TABLE 17 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 18 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 19 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 20 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CANDIDATE SCREENING, BY REGION, 2019-2030 (USD BILLION)
TABLE 21 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DE NOVO DRUG DESIGNING, BY REGION, 2019-2030 (USD BILLION)
TABLE 22 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DRUG OPTIMIZATION AND REPURPOSING, BY REGION, 2019-2030 (USD BILLION)
TABLE 23 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRECLINICAL TESTING, BY REGION, 2019-2030 (USD BILLION)
TABLE 24 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION, 2019-2030 (USD BILLION)
TABLE 25 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 26 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 27 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 28 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 29 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 30 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 31 US AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 32 US AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 33 US AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 34 US AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 35 US AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 36 CANADA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 37 CANADA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 38 CANADA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 39 CANADA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 40 CANADA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 41 EUROPE: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 42 EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 43 EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 44 EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 45 EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 46 EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 47 GERMANY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 48 GERMANY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 49 GERMANY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 50 GERMANY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 51 GERMANY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 52 FRANCE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 53 FRANCE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 54 FRANCE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 55 FRANCE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 56 FRANCE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 57 UK AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 58 UK AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 59 UK AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 60 UK AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 61 UK AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 62 ITALY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 63 ITALY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 64 ITALY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 65 ITALY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 66 ITALY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 67 SPAIN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 68 SPAIN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 69 SPAIN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 70 SPAIN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 71 SPAIN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 72 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 73 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 74 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 75 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 76 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 77 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 78 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 79 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 80 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 81 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 82 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 83 CHINA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 84 CHINA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 85 CHINA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 86 CHINA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 87 CHINA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 88 JAPAN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 89 JAPAN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 90 JAPAN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 91 JAPAN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 92 JAPAN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 93 INDIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 94 INDIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 95 INDIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 96 INDIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 97 INDIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 98 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 99 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 100 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 101 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 102 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 103 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 104 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 105 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 106 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 107 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 108 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 109 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 110 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 111 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 112 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 113 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET, BY REGION, 2018-2030 (USD BILLION)
TABLE 114 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 115 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 116 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 117 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 118 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 119 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 120 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 121 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 122 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 123 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 124 AFRICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 125 AFRICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 126 AFRICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 127 AFRICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 128 AFRICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 129 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)
TABLE 130 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)
TABLE 131 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)
TABLE 132 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)
TABLE 133 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
TABLE 134 MAJOR PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
TABLE 135 MOST ACTIVE PLAYER IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
TABLE 136 SERVICE/COMPANY LAUNCH
TABLE 137 MERGER/ACQUISITION
TABLE 138 PARTNERSHIP/COLLABORATION/AGREEMENT
TABLE 139 IBM: SOFTWARE/SERVICES OFFERED
TABLE 140 IBM: KEY DEVELOPMENTS
TABLE 141 ALPHABET INC.: SOFTWARE/SERVICES OFFERED
TABLE 142 ALPHABET INC.: KEY DEVELOPMENTS
TABLE 143 ATOMWISE INC.: SOFTWARE/SERVICES OFFERED
TABLE 144 ATOMWISE INC.: KEY DEVELOPMENTS
TABLE 145 DEEP GENOMICS: SOFTWARE/SERVICES OFFERED
TABLE 146 CLOUD PHARMACEUTICALS, INC.: SOFTWARE/SERVICES OFFERED
TABLE 147 CLOUD PHARMACEUTICALS, INC.: KEY DEVELOPMENTS
TABLE 148 MICROSOFT CORPORATION: SERVICES OFFERED
TABLE 149 INSILICO MEDICINE: SERVICES OFFERED
TABLE 150 CYCLICA: SERVICES OFFERED
TABLE 151 BENEVOLENTAI: SERVICES OFFERED
TABLE 152 EXSCIENTIA: SOFTWARES OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL AI IN DRUG DISCOVERY MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE AI IN DRUG DISCOVERY
FIGURE 4 DRIVER IMPACT ANALYSIS
FIGURE 5 RESTRAINT IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL AI IN DRUG DISCOVERY
FIGURE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2022 & 2030 (USD BILLION)
FIGURE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2022 & 2030 (USD BILLION)
FIGURE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2022 & 2030 (USD BILLION)
FIGURE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2022 & 2030 (USD BILLION)
FIGURE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)
FIGURE 13 GLOBAL AI IN DRUG DISCOVERY MARKET: BY REGION, 2022 & 2030 (USD BILLION)
FIGURE 14 GLOBAL AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
FIGURE 15 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 16 EUROPE: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 17 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 18 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
FIGURE 21 GLOBAL AI IN DRUG DISCOVERY MARKET: COMPETITIVE LANDSCAPE
FIGURE 22 IBM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 IBM: SWOT ANALYSIS
FIGURE 24 ALPHABET INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ALPHABET INC.: SWOT ANALYSIS
FIGURE 26 ATOMWISE INC.: SWOT ANALYSIS
FIGURE 27 MICROSOFT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 MICROSOFT CORPORATION: SWOT ANALYSIS
FIGURE 29 BENEVOLENTAI: SWOT ANALYSIS
FIGURE 30 EXSCIENTIA: FINANCIAL OVERVIEW SNAPSHOT

Product Code: MRFR/Pharma/7918-CR

Market Overview

The Artificial Intelligence in Drug Discovery Market is anticipated to register a substantial CAGR of 29.83% during the forecast period. The increasing reception of simulated intelligence in drug discovery, rising key initiatives for man-made intelligence in drug discovery, and the increasing number of man-made intelligence-powered drug discovery new companies are driving business sector development.

The reception of simulated intelligence in drug discovery is rising among industries, including drug and biotechnology organizations. This is essentially owing to the way that artificial intelligence offers progressed benefits to discovering drug particles and paces up the drug discovery process. Further, artificial intelligence gives significant insights to work on the designing, optimizing, and synthesizing of drugs. There are a few factors that are increasing the reception of man-made intelligence for drug discovery. The absolute most predominant ones include the rising incidences of ongoing illnesses and accuracy medicine, owing to the emerging way to deal with the counteraction and treatment of sicknesses. Besides, a few market members are increasing the accuracy of their drug portfolios, a cycle that has been seen to exhibit an increase in the reception of man-made intelligence advancements.

Market Segmentation

Based on product and service Artificial Intelligence in Drug Discovery, is classified into software and services. Based on a molecule type the market is divided into large molecules and small molecules. The Market of Artificial Intelligence in Drug Discovery based on technology is divided into machine learning, deep learning, and others.

Based on an indication the market is classified into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and others. Based on an application the market is categorized into target identification, candidate screening, de novo drug designing, drug optimization and repurposing, and preclinical testing.

Regional Insights

The North American artificial intelligence in the drug discovery market represented the biggest piece of the pie in 2022. This is because of the increasing incidences of ongoing illnesses, many leading new companies, and increasing drug Research and development investments in the region.

Europe's artificial intelligence in the drug discovery market represents the second-biggest piece of the pie because of the rising pervasiveness of uncommon illnesses across Europe and increasing the demand for a simulated intelligence-driven stage for drug discovery. Moreover, Germany's market of artificial intelligence

The Asia-Pacific artificial intelligence in drug discovery market is supposed to develop at a huge offer from 2023 to 2030. This is because of the rising weight of sickness and the tremendous number of biopharmaceutical industries that are adopting computer-based intelligence abilities in the Asia-Pacific region.

The rest of the World is fragmented into the Center East, Africa, and Latin America. Artificial intelligence in the drug discovery market in the previously mentioned regions is probably going to observe development because of the increasing demand for drugs because of the rising incidences of persistent and infectious illnesses.

Major Players

Key Companies in the Artificial Intelligence in Drug Discovery Market include IBM (US), Alphabet Inc (US), Atomwise Inc (US), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc (US), Microsoft corporation (US), Insilico Medicine (China), Cyclica (Canada), BenevolentAI (UK), and Exscientia (UK).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW
- 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
- 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING ADOPTION OF AI IN DRUG DISCOVERY
- 4.2.2 RISING STRATEGIC INITIATIVES FOR AI IN DRUG DISCOVERY
- 4.2.3 INCREASING NUMBER OF AI-POWERED DRUG DISCOVERY START-UPS
4.3 RESTRAINTS
- 4.3.1 SHORTAGE OF AI WORKFORCE
4.4 OPPORTUNITIES
- 4.4.1 EMERGING MARKETS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL AI IN DRUG DISCOVERY
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON SERVICE DEMAND
- 5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

6.1 OVERVIEW
6.2 SOFTWARE
6.3 SERVICES

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

7.1 OVERVIEW
7.2 LARGE MOLECULE
7.3 SMALL MOLECULE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

8.1 OVERVIEW
8.2 MACHINE LEARNING
8.3 DEEP LEARNING
8.4 OTHERS

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

9.1 OVERVIEW
9.2 IMMUNO-ONCOLOGY
9.3 NEURODEGENERATIVE DISEASES
9.4 CARDIOVASCULAR DISEASES
9.5 METABOLIC DISEASES
9.6 OTHERS

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

10.1 OVERVIEW
10.2 TARGET IDENTIFICATION
10.3 CANDIDATE SCREENING
10.4 DE NOVO DRUG DESIGNING
10.5 DRUG OPTIMIZATION AND REPURPOSING
10.6 PRECLINICAL TESTING

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

11.1 OVERVIEW
11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.2 CANADA
11.3 EUROPE
- 11.3.1 GERMANY
- 11.3.2 FRANCE
- 11.3.3 UK
- 11.3.4 ITALY
- 11.3.5 SPAIN
- 11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
- 11.4.1 CHINA
- 11.4.2 JAPAN
- 11.4.3 INDIA
- 11.4.4 AUSTRALIA
- 11.4.5 SOUTH KOREA
- 11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
- 11.5.1 MIDDLE EAST
- 11.5.2 AFRICA
- 11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 12.6.1 SERVICE/COMPANY LAUNCH
- 12.6.2 MERGER/ACQUISITION
- 12.6.3 PARTNERSHIP/COLLABORATION/AGREEMENT

13 COMPANY PROFILES

13.1 IBM
- 13.1.1 COMPANY OVERVIEW
- 13.1.2 FINANCIAL OVERVIEW
- 13.1.3 SOFTWARE/SERVICES OFFERED
- 13.1.4 KEY DEVELOPMENTS
- 13.1.5 SWOT ANALYSIS
- 13.1.6 KEY STRATEGIES
13.2 ALPHABET INC.
- 13.2.1 COMPANY OVERVIEW
- 13.2.2 FINANCIAL OVERVIEW
- 13.2.3 SOFTWARE/SERVICES OFFERED
- 13.2.4 KEY DEVELOPMENTS
- 13.2.5 SWOT ANALYSIS
- 13.2.6 KEY STRATEGIES
13.3 ATOMWISE INC.
- 13.3.1 COMPANY OVERVIEW
- 13.3.2 FINANCIAL OVERVIEW
- 13.3.3 SOFTWARE/SERVICES OFFERED
- 13.3.4 KEY DEVELOPMENTS
- 13.3.5 SWOT ANALYSIS
- 13.3.6 KEY STRATEGIES
13.4 DEEP GENOMICS
- 13.4.1 COMPANY OVERVIEW
- 13.4.2 FINANCIAL OVERVIEW
- 13.4.3 SOFTWARE/SERVICES OFFERED
- 13.4.4 KEY DEVELOPMENTS
- 13.4.5 KEY STRATEGIES
13.5 CLOUD PHARMACEUTICALS, INC.
- 13.5.1 COMPANY OVERVIEW
- 13.5.2 FINANCIAL OVERVIEW
- 13.5.3 SOFTWARE/SERVICES OFFERED
- 13.5.4 KEY DEVELOPMENTS
- 13.5.5 KEY STRATEGIES
13.6 MICROSOFT CORPORATION
- 13.6.1 COMPANY OVERVIEW
- 13.6.2 FINANCIAL OVERVIEW
- 13.6.3 SERVICES OFFERED
- 13.6.4 KEY DEVELOPMENTS
- 13.6.5 SWOT ANALYSIS
- 13.6.6 KEY STRATEGIES
13.7 INSILICO MEDICINE
- 13.7.1 COMPANY OVERVIEW
- 13.7.2 FINANCIAL OVERVIEW
- 13.7.3 SERVICES OFFERED
- 13.7.4 KEY DEVELOPMENTS
- 13.7.5 KEY STRATEGIES
13.8 CYCLICA
- 13.8.1 COMPANY OVERVIEW
- 13.8.2 FINANCIAL OVERVIEW
- 13.8.3 SERVICES OFFERED
- 13.8.4 KEY DEVELOPMENTS
- 13.8.5 KEY STRATEGIES
13.9 BENEVOLENTAI
- 13.9.1 COMPANY OVERVIEW
- 13.9.2 FINANCIAL OVERVIEW
- 13.9.3 SERVICES OFFERED
- 13.9.4 KEY DEVELOPMENTS
- 13.9.5 SWOT ANALYSIS
- 13.9.6 KEY STRATEGIES
13.10 EXSCIENTIA
- 13.10.1 COMPANY OVERVIEW
- 13.10.2 FINANCIAL OVERVIEW
- 13.10.3 SOFTWARES OFFERED
- 13.10.4 KEY DEVELOPMENTS
- 13.10.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES
14.2 RELATED REPORTS

創薬向けAIの世界市場の予測（～2030年）

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

目次

第1章エグゼクティブサマリー

第2章市場のイントロダクション

第3章調査手法

第4章市場力学

第5章市場要因の分析

第6章世界の創薬向けAI市場：製品・サービス別

第7章世界の創薬向けAI市場：分子タイプ別

第8章世界の創薬向けAI市場：技術別

第9章世界の創薬向けAI市場：適応症別

第10章世界の創薬向けAI市場：用途別

第11章世界の創薬向けAI市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Market Segmentation

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

創薬向けAIの世界市場の予測（～2030年）

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

第5章 市場要因の分析

第6章 世界の創薬向けAI市場：製品・サービス別

第7章 世界の創薬向けAI市場：分子タイプ別

第8章 世界の創薬向けAI市場：技術別

第9章 世界の創薬向けAI市場：適応症別

第10章 世界の創薬向けAI市場：用途別

第11章 世界の創薬向けAI市場：地域別

第12章 競合情勢

第13章 企業プロファイル

第14章 付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Market Segmentation

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

第1章エグゼクティブサマリー

第2章市場のイントロダクション

第3章調査手法

第4章市場力学

第5章市場要因の分析

第6章世界の創薬向けAI市場：製品・サービス別

第7章世界の創薬向けAI市場：分子タイプ別

第8章世界の創薬向けAI市場：技術別

第9章世界の創薬向けAI市場：適応症別

第10章世界の創薬向けAI市場：用途別

第11章世界の創薬向けAI市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録